8fbj
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 8fbj is ON HOLD until Paper Publication Authors: Description: Category: Unreleased Structures) |
|||
(2 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domains== | |
+ | <StructureSection load='8fbj' size='340' side='right'caption='[[8fbj]], [[Resolution|resolution]] 3.25Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[8fbj]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8FBJ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8FBJ FirstGlance]. <br> | ||
+ | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.25Å</td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8fbj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8fbj OCA], [https://pdbe.org/8fbj PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8fbj RCSB], [https://www.ebi.ac.uk/pdbsum/8fbj PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8fbj ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Computationally designed protein nanoparticles have recently emerged as a promising platform for the development of new vaccines and biologics. For many applications, secretion of designed nanoparticles from eukaryotic cells would be advantageous, but in practice, they often secrete poorly. Here we show that designed hydrophobic interfaces that drive nanoparticle assembly are often predicted to form cryptic transmembrane domains, suggesting that interaction with the membrane insertion machinery could limit efficient secretion. We develop a general computational protocol, the Degreaser, to design away cryptic transmembrane domains without sacrificing protein stability. The retroactive application of the Degreaser to previously designed nanoparticle components and nanoparticles considerably improves secretion, and modular integration of the Degreaser into design pipelines results in new nanoparticles that secrete as robustly as naturally occurring protein assemblies. Both the Degreaser protocol and the nanoparticles we describe may be broadly useful in biotechnological applications. | ||
- | + | Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domains.,Wang JYJ, Khmelinskaia A, Sheffler W, Miranda MC, Antanasijevic A, Borst AJ, Torres SV, Shu C, Hsia Y, Nattermann U, Ellis D, Walkey C, Ahlrichs M, Chan S, Kang A, Nguyen H, Sydeman C, Sankaran B, Wu M, Bera AK, Carter L, Fiala B, Murphy M, Baker D, Ward AB, King NP Proc Natl Acad Sci U S A. 2023 Mar 14;120(11):e2214556120. doi: , 10.1073/pnas.2214556120. Epub 2023 Mar 8. PMID:36888664<ref>PMID:36888664</ref> | |
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | [[Category: | + | </div> |
+ | <div class="pdbe-citations 8fbj" style="background-color:#fffaf0;"></div> | ||
+ | == References == | ||
+ | <references/> | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Large Structures]] | ||
+ | [[Category: Synthetic construct]] | ||
+ | [[Category: Bera AK]] | ||
+ | [[Category: Khmelinskaia A]] | ||
+ | [[Category: King NP]] | ||
+ | [[Category: Wang JY]] |
Current revision
Improving the secretion of designed protein assemblies through negative design of cryptic transmembrane domains
|